Valuation: BOIRON

Market Cap 33Cr 36Cr 31Cr 28Cr 52Cr 3.4TCr 54Cr 370.31Cr 146.38Cr 1.83TCr 136.41Cr 133.56Cr 5.79TCr P/E 2024
41x
P/E 2025 16.1x
Enterprise Value 28Cr 31Cr 26Cr 24Cr 45Cr 2.91TCr 46Cr 316.87Cr 125.26Cr 1.57TCr 116.73Cr 114.28Cr 4.96TCr EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
12.84%
Yield 2024
4.48%
Yield 2025 4.46%
1 week+0.26%
Current month+2.14%
1 month+5.23%
3 months-27.10%
6 months-28.73%
Current year-36.96%
1 week 18.85
Extreme 18.85
19.25
1 month 17.45
Extreme 17.45
20.3
Current year 16.9
Extreme 16.9
30.95
1 year 16.9
Extreme 16.9
32.25
3 years 16.9
Extreme 16.9
42.8
5 years 16.9
Extreme 16.9
56.5
10 years 16.9
Extreme 16.9
92.7
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2025
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Chairman 65 01/07/2011
Director/Board Member 54 10/03/2010
Director/Board Member 51 23/05/2013
Date Insider Type Main position Quantity % Market Cap. Importance
29/10/23 Sell

Director

1,98,664 1.1323%
29/10/23 Sell

Director

4,62,964 2.6387%
29/10/23 Sell

Director

4,748 0.0271%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+0.26%-28.86%-52.06% 36Cr
-1.80%-5.01%+29.17%+126.86% 1,23200Cr
-2.12%-5.79%+31.89%+78.17% 66TCr
-1.11%-4.14%+21.19%+104.09% 51TCr
-1.04%-1.80%+28.69%+68.33% 38TCr
-2.86%-8.85%+40.92%+30.45% 34TCr
-3.22%-5.20%+24.48%+50.97% 29TCr
-2.51%-4.49%-2.15%+31.64% 28TCr
-0.94%-5.83%+28.45%+65.75% 24TCr
-1.12%-0.60%+30.35%+119.66% 21TCr
Average -1.67%-2.15%+20.41%+62.39% 41TCr
Weighted average by Cap. -1.86%-2.67%+27.12%+87.31%

Financials

2024 2025
Net sales 49Cr 53Cr 45Cr 41Cr 77Cr 5TCr 80Cr 544.45Cr 215.22Cr 2.7TCr 200.56Cr 196.36Cr 8.51TCr 50Cr 55Cr 46Cr 42Cr 79Cr 5.13TCr 82Cr 559.57Cr 221.2Cr 2.77TCr 206.13Cr 201.82Cr 8.75TCr
Net income 1.13Cr 1.24Cr 1.05Cr 94.59L 1.78Cr 116.15Cr 1.85Cr 13Cr 5Cr 63Cr 4.66Cr 4.57Cr 197.97Cr 3.26Cr 3.58Cr 3.02Cr 2.72Cr 5.13Cr 334.47Cr 5.33Cr 36Cr 14Cr 180.53Cr 13Cr 13Cr 570.07Cr
Net Debt -4.97Cr -5.45Cr -4.6Cr -4.15Cr -7.82Cr -509.63Cr -8.12Cr -56Cr -22Cr -275.08Cr -20Cr -20Cr -868.62Cr -4.79Cr -5.25Cr -4.42Cr -3.99Cr -7.52Cr -490.34Cr -7.82Cr -53Cr -21Cr -264.66Cr -20Cr -19Cr -835.73Cr
Projected Income Statement - Annual - BOIRON
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
2,623
Date Price Change Volume
19/26/19 €19.10 0.00% 258
18/26/18 €19.10 -0.78% 649
17/26/17 €19.25 +1.32% 1,291
16/26/16 €19.00 -1.04% 1,591
13/26/13 €19.20 +0.79% 1,710

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - BOIRON